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Abstract
Introduction: Providing information on cancerous tissue samples during a surgical operation can help surgeons
delineate the limits of a tumoral invasion more reliably. Here, we describe the use of metabolic profiling of a colon
biopsy specimen by high resolution magic angle spinning nuclear magnetic resonance spectroscopy to evaluate
tumoral invasion during a simulated surgical operation.
Case presentation: Biopsy specimens (n = 9) originating from the excised right colon of a 66-year-old Caucasian
women with an adenocarcinoma were automatically analyzed using a previously built statistical model.
Conclusions: Metabolic profiling results were in full agreement with those of a histopathological analysis. The
time-response of the technique is sufficiently fast for it to be used effectively during a real operation (17 min/
sample). Metabolic profiling has the potential to become a method to rapidly characterize cancerous biopsies in
the operation theater.
Introduction
Providing information on cancerous tissue samples in
real-time during a surgical operation can help surgeons
delineate more precisely the limits of a tumoral invasion.
Currently, only a histopathological examination of the
tissue specimen performed under extemporaneous condi-
tions can answer this question reliably. However, this
analysis is labor-intensive and its response time can
exceed 30 minutes. Metabolic profiling of unprocessed
biopsy specimens by
1H high resolution magic angle
spinning nuclear magnetic resonance (HRMAS NMR)
spectroscopy [1-3] has the potential to efficiently distin-
guish cancerous and healthy tissues [4-10]. However,
until now, no attempts have been made to utilize this
technique as an additional diagnostic tool in the context
of a surgical operation. Recently, a general description of
the possibilities offered by this methodology has appeared
in the literature [11]. In this paper, a proof of principle of
real-time metabolic profiling by
1H HRMAS NMR during
a surgical operation is given, using as a model the excised
colon of a patient with an adenocarcinoma. The meta-
bolic profiles of the different tissue samples of the patient
were analyzed, under the time-constraints of a real surgi-
cal operation, using a previously established statistical
partial-least square discriminant analysis model (R
2Y=
0.80, Q
2 = 0.76) built from 35 healthy colon tissue sam-
ples and 39 adenocarcinoma samples. This model is
based essentially on the spectral windows corresponding
to the chemical shifts of taurine, glutamate, aspartate,
myo-inositol and glucose (Figure 1) [12]. The model was
used to automatically classify, without human interven-
tion, the new biopsy specimen.
Case presentation
A 66-year-old Caucasian women presented to our hospi-
tal with anemia (hemoglobin 9.1 g/dL, hematocrit 31%)
and an abdominal scanner examination revealed the
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underwent an open right hemicolectomy with radical
lymphadenectomy. The tumor was diagnosed in histo-
pathology as a differentiated adenocarcinoma with angio-
, lympho- (2/13) and neuroinvasion and staged as
pT4aN1M0 according to the tumor-node-metastasis clas-
sification. Molecular analysis of the samples revealed
microsatellites-stable tumor with p53 gene alteration. No
tumor infiltration was observed in the margin of the
resected colon.
Discussion
Nine biopsy specimens from our patient’ss e g m e n t a lc o l o n
resection were prepared in 30 μL inserts (preparation
time, two minutes per insert) and inserted into a 500 MHz
NMR magnet (for detailed experimental procedure see
[12]). One-dimensional HRMAS NMR data were then
acquired under exactly the same conditions as the ones
used to build the statistical model (3°C, rotation speed
3502 Hz, total experiment time 14 minutes). Immediately
after data acquisition, the peak integral within each 0.01
ppm region was computed and normalized with respect to
the total integral of the spectrum in the 4.7 ppm to
0.5 ppm region using AMIX software (Bruker GmbH,
Germany). Datasets were then imported into the SIMCA
P 11.0 software (Umetrics AB, Umeå, Sweden), pre-
processed using unit variance scaling and input into the
previously described statistical model. The model then
Figure 1 Statistical partial-least square discriminant analysis model used for the blind test analysis of colon biopsies. The model was
developed and validated using a cohort of 74 colorectal biopsies (control n = 35, adenocarcinoma n = 39) and histopathological criteria using
the spectral region corresponding to the taurine, glutamate, aspartate, myo-inositol and glucose resonances. Cancerous and control colon biopsy
specimens are represented by red and black boxes respectively. The two component partial-least square discriminant analysis model is
characterized by the following parameters: R
2Y = 0.80 and Q
2 = 0.76. The high Q
2 value indicates the high predictive capabilities for the model.
Representative one-dimensional
1H Carr-Purcell-Meiboom-Gill high resolution magic angle spinning nuclear magnetic resonance spectra of
control and adenocarcinoma colorectal tissues originating from the same patient are shown on the left side. Partial metabolite assignment in
the 4.7 ppm to 0.5 ppm region is indicated. The numbers refer to the following metabolites: (1) isoleucine, (2) leucine, (3) valine, (4) ethanol, (9)
lactate, (10) lysine, (11) alanine, (12) acetate, (13) glutamate, (14) methionine, (15) glutamine, (16) aspartic acid, (17) phosphoethanolamine, (18)
choline, (19) phosphorylcholine, (20) glycerophosphocholine, (21) arginine, (22) taurine, (23) proline, (24) scyllo-inositol, (25) myo-inositol, (26)
glycine, (27) threonine, (28) glycerol, (29) beta-glucose, (30) alpha-glucose, (31) serine, (32) creatine, (33) asparagine, (34) tyrosine, (35)
phenylalanine, (36) ascorbic acid and (37) succinic acid.
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the nine samples as either cancerous or control (data ana-
lysis time, one minute).
The results of the classification process obtained for
our patient are presented in Figure 2. In this score plot,
it is observed that one set of four biopsy specimens
(biopsies 3, 4, 5 and 6) falls clearly within the control
region of the statistical domain, whereas four biopsy
specimens (biopsies 1, 2, 7 and 9) appear in the adeno-
carcinoma region. Biopsy 8 is classified in the border
region that separates control samples from adenocarci-
nomas. A complementary way of analysing the classifica-
tion data is to check the value of the predicted Y value
for each biopsy specimen. In our model, a Y value of 0
corresponds to healthy tissues whereas a Y value of 1
corresponds to an adenocarcinoma. The predicted Y
value for biopsy specimens 3, 4, 5 and 6 was found to
be 0.15, 0.16, 0.01 and 0.15 respectively whereas the pre-
dicted Y value for biopsy specimens 1, 2, 7, 8 and 9 was
equal to 1.5, 1.2, 1.2, 0.43 and 1.10 respectively. Clearly,
these values reflect the position of each biopsy specimen
in Figure 2.
A histopathological analysis was performed on mirror
samples and on the nine biopsy specimen used for the
HRMAS analysis. Quantitative histopathological analysis
provided very similar results on mirror samples and on
biopsy specimens, despite the fact that some tissue altera-
tion due to rotation was observed. Figure 3 displays a
macroscopic view of the colon specimen used with the
tumoral zone at the center and the different histopatholo-
gical sections analyzed. The histopathological analysis
revealed that biopsy specimens 1, 7, 2, 9 and 8 contained
60%, 60%, 50%, 30% and 10% of tumoral cells respectively,
whereas biopsy specimens 3, 4, 5 and 6, which are located
further away from the tumor, contained 0% tumoral cells.
When comparing these results with those obtained from
metabolic profiling, the results show a remarkable agree-
ment. The results obtained on our patient in Figure 2
show clearly that the position of the different biopsies in
the statistical model faithfully reproduce the results of the
Figure 2 Blind test classification. Automatic classification of nine colon biopsy specimens from a patient affected with an adenocarcinoma
using the metabolic model presented in Figure 1. Samples 1, 7, 2 and 9 are classified as adenocarcinomas, whereas samples 3, 4, 5 and 6 are
classified as control. Sample 8 falls in the border region.
Piotto et al. Journal of Medical Case Reports 2012, 6:22
http://www.jmedicalcasereports.com/content/6/1/22
Page 3 of 6Figure 3 Combined histopathological analysis and metabolic profiling of colon samples originating from a patient affected with an
adenocarcinoma. A macroscopic view of the colectomy specimen (total length 10 cm) containing an invasive adenocarcinoma with a whitish
fungating appearance and a section of the specimen stained with hematoxylin and eosin (H&E). (A) Histopathological analysis: The most invasive
part of the tumor corresponds to boxes 1, 7 and 9, whereas normal mucosa is represented by boxes 3, 4, 5 and 6. Boxes 2 and 8 correspond to
submucosa and serosa tissue respectively. Tissues corresponding to all the nine boxes were embedded in paraffin and stained with H&E for
histological analysis (5 μm thickness). Evaluation of H&E staining was performed by light microscopy using a 10× eye-piece with a 20× or a 40×
objective. The percentage of tumoral cells indicated was evaluated by a semi-quantitative method and by two pathologists to confirm the
diagnosis. (B) Metabolic profiling: the histological sections have been replaced by the corresponding one-dimensional
1H high resolution magic
angle spinning nuclear magnetic resonance spectra. The most representative metabolites of control and adenocarcinoma samples are indicated
on the spectra of samples 2 and 3. Samples 2 and 8 contain a higher amount of lipids (large peaks at 0.91 ppm, 1.30 ppm, 1.60 ppm, 2.04 ppm,
2.27 ppm and 2.80 ppm).
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contain the highest number of tumoral cells and are
grouped together in the adenocarcinoma region. Control
biopsy specimens 3, 4, 5 and 6 correspond to the control
region of the statistical model. Biopsy 8 is certainly the
most interesting case since it contains only 10% of tumoral
cells and the model positions it properly at the border
region between control and adenocarcinoma.
Adenocarcinoma are characterized, in decreasing order
of importance, by a higher amount of taurine, glutamate
and aspartate than control biopsy specimens, which con-
tain more myo-inositol and glucose. Although a detailed
analysis of the metabolic pathways affected in ardenocarci-
noma cells is out of the scope of this manuscript, it is
clear that our results are in full agreement with the War-
burg phenomenon [13] since adenocarcinoma cells are
clearly depleted in glucose. Figure 3 presents the
1H
HRMAS NMR spectra corresponding precisely to the
biopsy specimens analyzed by histopathology. The higher
content of the metabolites taurine (3.42 ppm), glutamate
(2.34 ppm) and aspartate (2.80 ppm) is clearly visible in
the spectra of tumoral cells, whereas the intensity of myo-
inositol (4.05 ppm) and glucose (4.65 ppm) increases sig-
nificantly in the control biopsy specimens. Thus, the
results obtained show that metabolic profiling is indeed
able to provide real-time analysis of biopsy samples.
The total time per sample in our case for a full analysis,
which consists of sample preparation, data acquisition and
statistical analysis, is about 17 minutes per sample. Inter-
estingly, this time is equivalent to that typically observed
in the case of an extemporaneous histological analysis but
still needs to be reduced in the context of an operation.
Realistically, future progress in sample preparation, data
acquisition and analysis should be able to reduce this time
to less than 10 minutes per biopsy sample. In that respect,
automation and simultaneous analysis of multiple samples
will play a crucial role for the future development of these
techniques.
Conclusion
Adenocarcinoma of the colon was chosen as a test case
for this study for two reasons. First, the segmental colon
resection allows the preparation of several biopsies with
different levels of tumoral cell infiltration, in particular at
the level of the transitional zones. Second, we have pre-
viously developed a robust statistical model for this kind
of pathology. This model was essential for the success of
the current analysis. From a medical point of view, the
approach presented here could have some extremely
important applications in areas of surgery that require a
surgical strategy to be decided under intraoperative con-
ditions, or in cases where it is extremely difficult to
delineate with adequate precision the exact zone of
tumoral infiltration. Neurosurgery or surgery of the
pancreas, in particular, is a field that would benefit
immensely from this kind of technology. The prospects
of real-time metabolic profiling by HRMAS NMR are
therefore extremely promising and methodological as
well as technical developments should make this type of
analysis even faster.
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